Current evidence of skin barrier dysfunction in human and canine atopic dermatitis

Veterinary Dermatology

Volumn 22, Issue 3, 2011, Pages 239-248

  Marsella, Rosanna ^a   Olivry, Thierry ^b   Carlotti, Didier Noel ^c  

^a University of Florida   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c CLINIQUE VÉTÉRINAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; DOG; DOG DISEASE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; HUMANS;

EID: 79955669779     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2011.00967.x     Document Type: Article

References (106)

1. Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. Journal of Investigative Dermatology 2009; 129: 1892-908.
2. Sehra S, Tuana FM, Holbreich M et al. Scratching the surface: towards understanding the pathogenesis of atopic dermatitis. Critical Reviews in Immunology 2008; 28: 15-43.
3. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Current Opinion in Allergy and Clinical Immunology 2009; 9: 437-46.
4. Ohnishi Y, Okino N, Ito M et al. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clinical and Diagnostic Laboratory Immunology 1999; 6: 101-4.
5. Marsella R, Olivry T. Animal models of atopic dermatitis. Clinics in Dermatology 2003; 21: 122-33.
6. Griffin CE, DeBoer DJ. The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis. Veterinary Immunology and Immunopathology 2001; 81: 255-69.
7. Marsella R, Nicklin C, Lopez J. Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites. Veterinary Dermatology 2006; 17: 306-12.
8. Olivry T, Deangelo KB, Dunston SM et al. Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis. Veterinary Dermatology 2006; 17: 95-102.
9. Marsella R, Olivry T, Maeda S. Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles. Veterinary Dermatology 2006; 17: 111-20.
10. Lodén M. Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products. Acta Dermato-Venereologica. Supplementum (Stockholm) 1995; 192: 1-48.
11. Triebskorn A. Methods for measuring the symptoms of "dry skin". Zeitschrift für Hautkrankheiten 1988; 63(Suppl. 3): 16-9.
12. Oestmann E, Lavrijsen AP, Hermans J, Ponec M. Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra- and inter-individual variability. British Journal of Dermatology 1993; 128: 130-6.
13. Pinnagoda J, Tupker RA, Agner T et al. Guidelines for transepidermal water loss (TEWL) measurement. A report from the standardization group of the European society of contact dermatitis. Contact Dermatitis 1990; 22: 164-78.
14. Gupta J, Grube E, Ericksen MB et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. Journal of Allergy and Clinical Immunology 2008; 121: 725-30.
15. Hon KL, Wong KY, Leung TF et al. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. American Journal of Clinical Dermatology 2008; 9: 45-50.
16. Loden M, Olsson H, Axell T et al. Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin. British Journal of Dermatology 1992; 126: 137-41.
17. Lee C-H, Chuang H-Y, Shih C-C et al. Transepidermal water loss, serum IgE and β-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. British Journal of Dermatology 2006; 154: 1100-7.
18. Seidnari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically normal skin. Acta Dermato-Venereologica 1995; 75: 429-33.
19. Boralevi F, Hubiche T, Leaute-Labrze C et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants - determining the role of epidermal barrier impairments. Allergy 2008; 63: 205-10.
20. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Dermato-Venereologica 1985; 65: 102-5.
21. Kim DW, Park JY, Na GY et al. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis. International Journal of Dermatology 2006; 45: 698-701.
22. Nicander I, Nyrn M, Emtestam L et al. Baseline electrical impedance measurements at various skin sites - related to age and sex. Skin Research and Technology 1997; 3: 252-8.
23. Yosipovitch G, Maayan-Metzger A, Merlob P et al. Skin barrier properties in different body areas in neonates. Pediatrics 2000; 106: 105-8.
24. Nikolovski J, Stamatas GN, Kollias N et al. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. Journal of Investigative Dermatology 2008; 128: 1728-36.
25. Wilhelm KP, Cua AB, Maibach HI. Skin aging. Effect of transepidermal water loss, stratum corneum hydration, skin surface pH and casual sebum content. Archives of Dermatology 1991; 127: 1806-9.
26. Hubiche T, Ged C, Benard A et al. Analysis of SPINK5, KLK7 and FLG genotypes in a French atopic dermatitis cohort. Acta Dermato-Venereologica 2007; 87: 499-505.
27. Mori T, Ishida K, Mukumoto S et al. Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis. British Journal of Dermatology 2010; 162: 83-90.
28. Cohen JC, Hartman DG, Garofalo MJ et al. Comparison of closed chamber and open chamber evaporimetry. Skin Research and Technology 2009; 15: 51-4.
29. Imhof RE, De Jesus ME, Xiao P et al. Closed-chamber transepidermal water loss measurement: microclimate, calibration and performance. International Journal of Cosmetic Science 2009; 31: 97-118.
30. Shah JH, Zhai H, Maibach HI. Comparative evaporimetry in man. Skin Research and Technology 2005; 11: 205-8.
31. Laudańska H, Reduta T, Szmitkowska D. Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement. Roczniki Akademii Medycznej w Białymstoku 2003; 48: 123-7.
32. Jemec GB, Serup J. Epidermal hydration and skin mechanics. The relationship between electrical capacitance and the mechanical properties of human skin in vivo. Acta Dermato-Venereologica 1990; 70: 245-7.
33. Masukawa Y, Narita H, Sato H et al. Comprehensive quantification of ceramide species in human stratum corneum. Journal of Lipid Research 2009; 50: 1708-19.
34. Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. American Journal of Clinical Dermatology 2005; 6: 215-23.
35. Coderch L, López O, de la Maza A et al. Ceramides and skin function. American Journal of Clinical Dermatology 2003; 4: 107-29.
36. Masukawa Y, Narita H, Shimizu E et al. Characterization of overall ceramide species in human stratum corneum. Journal of Lipid Research 2008; 49: 1466-76.
37. Mizutani Y, Mitsutake S, Tsuji K et al. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 2009; 91: 784-90.
38. Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound ω-hydroxyceramides in atopic dermatitis. Journal of Investigative Dermatology 2002; 119: 166-73.
39. Farwanah H, Raith K, Neubert RH et al. Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Archives of Dermatologic Research 2005; 296: 514-21.
40. Jensen JM, Fölster-Holst R, Baranowsky A et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. Journal of Investigative Dermatology 2004; 122: 1423-31.
41. Imokawa G. A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Journal of Dermatological Science 2009; 55: 1-9.
42. Hara J, Higuchi K, Okamoto R et al. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. Journal of Investigative Dermatology 2000; 115: 406-13.
43. Murata Y, Ogata J, Higaki Y et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? Journal of Investigative Dermatology 1996; 106: 1242-9.
44. Okamoto R, Arikawa J, Ishibashi M et al. Sphingosyl-phosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. Journal of Lipid Research 2003; 44: 93-102.
45. Peiser M, Zuberbier T, Wanner R et al. Atopic skin is associated with a lack of phosphatidylcholine-sphingomyelin transacylase activity. Journal of Investigative Dermatology 2007; 12: 973-5.
46. Chamlin SL, Kao J, Frieden IJ et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. Journal of the American Academy of Dermatology 2002; 47: 198-208.
47. Madaan A. Epiceram for the treatment of atopic dermatitis. Drugs of Today (Barcelona, Spain) 2008; 44: 751-5.
48. Seguchi T, Cui CY, Kusuda S et al. Decreased expression of filaggrin in atopic skin. Archives of Dermatological Research 1996; 288: 442-6.
49. Irvine AD, McLean WH. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. Journal of Investigative Dermatology 2006; 126: 1200-2.
50. Nomura T, Sandilands A, Akiyama M et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. Journal of Allergy and Clinical Immunology 2007; 119: 434-40.
51. Hamada T, Sandilands A, Fukuda S et al. De novo occurrence of the filaggrin mutation p.R501X with prevalent mutation c.3321delA in a Japanese family with ichthyosis vulgaris complicated by atopic dermatitis. Journal of Investigative Dermatology 2008; 128: 1323-5.
52. Ekelund E, Liedén A, Link J et al. Loss-of-function variants of the filaggrin gene are associated with atopic eczema and associated phenotypes in Swedish families. Acta Dermato-Venereologica 2008; 88: 15-9.
53. Baurecht H, Irvine AD, Novak N et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. Journal of Allergy and Clinical Immunology 2007; 120: 1406-12.
54. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics 2006; 38: 441-6.
55. O'Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clinical and Experimental Allergy 2010; 40: 965-72.
56. Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. Journal of Allergy and Clinical Immunology 2006; 118: 214-9.
57. Hudson TJ. Skin barrier function and allergic risk. Nature Genetics 2006; 38: 399-400.
58. Weidinger S, Rodríguez E, Stahl C et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. Journal of Investigative Dermatology 2007; 127: 724-6.
59. McGrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends in Molecular Medicine 2008; 14: 20-7.
60. Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. Journal of Allergy and Clinical Immunology 2007; 120: 150-5.
61. Irvine AD. Fleshing out filaggrin phenotypes. Journal of Investigative Dermatology 2007; 127: 504-7.
62. Henderson J, Northstone K, Lee SP et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. Journal of Allergy and Clinical Immunology 2008; 121: 872-7.
63. Brown SJ, Irvine AD. Atopic eczema and the filaggrin story. Seminars in Cutaneous Medicine and Surgery 2008; 27: 128-37.
64. Moniaga CS, Egawa G, Kawasaki H et al. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. American Journal of Pathology 2010; 176: 2385-93.
65. Caubet C, Jonca N, Brattsand M et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. Journal of Investigative Dermatology 2004; 122: 1235-44.
66. Borgoño CA, Michael IP, Komatsu N et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. Journal of Biological Chemistry 2007; 282: 3640-52.
67. Vasilopoulos Y, Cork MJ, Murphy R et al. Genetic association between an AACC insertion in the 3' UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. Journal of Investigative Dermatology 2004; 123: 62-6.
68. Komatsu N, Saijoh K, Kuk C et al. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients. Experimental Dermatology 2007; 16: 513-9.
69. Voegeli R, Rawlings AV, Breternitz M et al. Increased stratum corneum serine protease activity in acute eczematous atopic skin. British Journal of Dermatology 2009; 161: 70-7.
70. Voegeli R, Rawlings AV, Doppler S et al. Increased basal transepidermal water loss leads to elevation of some but not all stratum corneum serine proteases. International Journal of Cosmetic Science 2008; 30: 435-42.
71. Tarroux R, Assalit MF, Licu D et al. Variability of enzyme markers during clinical regression of atopic dermatitis. Skin Pharmacology and Applied Skin Physiology 2002; 15: 55-62.
72. Badertscher K, Brönnimann M, Karlen S et al. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Achives of Dermatological Research 2005; 296: 503-6.
73. Komatsu N, Saijoh K, Jayakumar A et al. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. Journal of Investigative Dermatology 2008; 128: 1148-59.
74. Walley AJ, Chavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease. Nature Genetics 2001; 29: 175-8.
75. Kato A, Fukai K, Oiso N et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. British Journal of Dermatology 2003; 148: 665-9.
76. Nishio Y, Noguchi E, Shibasaki M et al. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes and Immunology 2003; 4: 515-7.
77. Roedl D, Traidl-Hoffmann C, Ring J et al. Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis. Journal of European Academy of Dermatology and Venereology 2009; 23: 1263-6.
78. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Experimental Dermatology 2008; 17: 1063-72.
79. Fartasch M, Bassukas ID, Diepgen TL. Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: an ultrastructural study. British Journal of Dermatology 1993; 128: 1-9.
80. Fartasch M, Bassukas ID, Diepgen TL. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. British Journal of Dermatology 1992; 127: 221-7.
81. Watson A, Fray T, Clarke S et al. Reliable use of the ServoMed evaporimeter EP2 to assess transepidermal water loss in the canine. Journal of Nutrition 2002; 132: 1661S-4S.
82. Shimada K, Yoshihara T, Konno K et al. Increase in transepidermal water loss and decrease in ceramide content in the lesional and non-lesional skin of canine atopic dermatitis. Veterinary Dermatology 2008; 19: 19.
83. Shimada K, Yoshihara T, Yamamoto M et al. Transepidermal water loss (TEWL) reflects skin barrier function of dog. The Journal of Veterinary Medical Science 2008; 70: 841-3.
84. Beco L, Fontaine J. Cornéométrie et perte d'eau transépidermique: validation des techniques chez des chiens sains. Annales de Médecine Vétérinaire 2000; 144: 329-33.
85. Lau-Gillard PJ, Hill PB, Chesney CJ et al. Evaluation of a hand-held evaporimeter (VapoMeter) for the measurement of transepidermal water loss in healthy dogs. Veterinary Dermatology 2010; 21: 136-45.
86. Oh WS, Oh TH. Mapping of the dog skin based on biophysical measurements. Veterinary Dermatology 2010; 21: 367-72.
87. Oh WS, Oh TH. Measurement of transepidermal water loss from clipped and unclipped anatomical sites on the dog. Australian Veterinary Journal 2009; 87: 409-12.
88. Hightower K, Marsella R, Creary E et al. Evaluation of transepidermal water loss in canine atopic dermatitis: a pilot study in beagle dogs sensitized to house dust mites. Veterinary Dermatology 2010; 21: 89-96.
89. Reiter LV, Torres SMF, Wertz PW. Characterization and quantification of ceramides in the non-lesional skin of canine patients with atopic dermatitis compared to controls. Veterinary Dermatology 2009; 20: 260-6.
90. Bardagi M, Vala H, Fondevila D et al. Immunohistochemical detection of filaggrin in the skin of different species. Veterinary Dermatology 2007; 18: 388.
91. Marsella R, Samuleson D, Harrington L. Evaluation of filaggrin expression in sensitized atopic beagles and in normal controls before and after allergen exposure. Veterinary Dermatology 2009; 20: 547-54.
92. Santoro D, Marsella R, Bunick D et al. Expression and distribution of canine filaggrin in the skin of healthy and atopic beagles. Veterinary Dermatology 2010; 21: 323.
93. Chervet L, Galichet A, McLean WH et al. Missing C-terminal filaggrin expression, NFkappaB activation and hyperproliferation identify the dog as a putative model to study epidermal dysfunction in atopic dermatitis. Experimental Dermatology 2010; 19: e343-6.
94. Barros Roque J, O'Leary CA, Kyaw-Tanner M et al. Haplotype sharing excludes canine orthologous Filaggrin locus in atopy in West Highland White Terriers. Animal Genetics 2009; 40: 793-4.
95. Wood SH, Clements DN, Ollier WE et al. Gene expression in canine atopic dermatitis and correlation with clinical severity scores. Journal of Dermatological Science 2009; 55: 27-33.
96. Stenshamn K, Bongcam-Rudloff E, Salmon Hillbertz N et al. Evaluation of kallikrein7 as a disease-causing gene for canine atopic dermatitis using microsatellite-based association mapping. Animal Genetics 2006; 377: 601-3.
97. Inman AO, Olivry T, Dunston SM et al. Electron microscopic observations of stratum corneum intercellular lipids in normal and atopic dogs. Veterinary Pathology 2001; 38: 720-3.
98. Piekutowska A, Pin D, Rème CA et al. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. Journal of Comparative Pathology 2008; 138: 197-203.
99. Marsella R, Samuelson D, Doerr K. Transmission electron microscopy studies in an experimental model of canine atopic dermatitis. Veterinary Dermatology 2010; 21: 81-8.
100. Dunstan R, Herdt TH, Olivier B et al. Age and breed-related differences in canine skin surface lipids and pH. Advances in Veterinary Dermatology 2000; 4: 37-42.
101. Wirén K, Nohlgård C, Nyberg F et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. Journal of the European Academy of Dermatology and Venereology 2009; 23: 1267-72.
102. Chamlin SL, Frieden IJ, Fowler A et al. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Archives in Dermatology 2001; 137: 1110-2.
103. Watson AL, Fray TR, Bailey J et al. Dietary constituents are able to play a beneficial role in canine epidermal barrier function. Experimental Dermatology 2006; 15: 74-81.
104. Marsh KA, Ruedisueli FL, Coe SL et al. Effects of zinc and linoleic acid supplementation on the skin and coat quality of dogs receiving a complete and balanced diet. Veterinary Dermatology 2000; 11: 277-84.
105. Campbell KL, Dorn GP. Effects of oral sunflower oil and olive oil on serum and cutaneous fatty acid concentrations in dogs. Research in Veterinary Science 1992; 53: 172-8.
106. Fujimura M. Up-to-date information about canine atopic dermatitis and clinical effects of topical product for improvement of skin barrier function. Companion Animal Practice Japan 2010; 2: 80-5.